DeAnna Friedman-Klabanoff

Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials

Jenell Stewart, Meighan Krows, Torin Schaafsma et al. · JAMA Network Open · 2022 · 53 citations · Full text

Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership

David M. Herrington, John W. Sanders, Thomas F. Wierzba et al. · BMC Infectious Diseases · 2021 · 40 citations · Full text

The Controlled Human Malaria Infection Experience at the University of Maryland

DeAnna Friedman-Klabanoff, Matthew B. Laurens, Andrea A. Berry et al. · American Journal of Tropical Medicine and Hygiene · 2019 · 23 citations · Full text

Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing

DeAnna Friedman-Klabanoff, Andrea A. Berry, Mark A. Travassos et al. · Vaccine · 2021 · 23 citations · Full text

Vaccination, Vaccine Development, First-in-human Clinical Testing +9

Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial

DeAnna Friedman-Klabanoff, Megan Birkhold, Mara Short et al. · EBioMedicine · 2022 · 19 citations · Full text